FDA approves gemtuzumab ozogamicin for treatment of AML
admin 14th September 2017 Uncategorised 0American Pharmacists Association News More: FDA approves gemtuzumab ozogamicin for treatment of AML Source: MDlinx
read moreAmerican Pharmacists Association News More: FDA approves gemtuzumab ozogamicin for treatment of AML Source: MDlinx
read moreFDA Press Announcements More: FDA approves Mylotarg for treatment of acute myeloid leukemia Source: MDlinx
read morePharmacy Times More: FDA approves mylotarg for AML treatment Source: MDlinx
read moreAmerican Pharmacists Association News More: FDA approves first gene therapy in the United States Source: MDlinx
read moreMarking a big step in its march toward potential approval, GlaxoSmithKline’s shingles vaccine candidate Shingrix won the support of an FDA expert panel Wednesday. The shot, slated to be a blockbuster, now heads to the FDA for an October action
read moreThe FDA has sent a warning letter to a New York-based homeopathic medication maker, marking the third warning in as many months that the FDA has sent to makers of the natural products. More: FDA sends warning to third homeopathic
read more© 1994 - 2024 B.M. Pharmaceuticals